For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) closed the day trading at $8.62 down -1.03% from the previous closing price of $8.71. In other words, the price has decreased by -$1.03 from its previous closing price. On the day, 0.54 million shares were traded. AVAH stock price reached its highest trading level at $8.73 during the session, while it also had its lowest trading level at $8.6.
Ratios:
For a better understanding of AVAH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.48. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 164.49 whereas as Long-Term Debt/Eq ratio is at 143.34.
On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $11. JP Morgan Upgraded its Underweight to Neutral on September 18, 2025, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 24 ’25 when VIGANO PAUL R sold 1,500,000 shares for $9.00 per share. The transaction valued at 13,500,000 led to the insider holds 362,746 shares of the business.
J.H. Whitney Equity Partners V sold 1,251,909 shares of AVAH for $11,267,181 on Oct 24 ’25. The 10% Owner now owns 19,292,787 shares after completing the transaction at $9.00 per share. On Oct 24 ’25, another insider, WILLIAMS ROBERT M JR, who serves as the 10% Owner of the company, sold 1,500,000 shares for $9.00 each. As a result, the insider received 13,500,000 and left with 362,746 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 1800816000 and an Enterprise Value of 3158407168. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.94, and their Forward P/E ratio for the next fiscal year is 13.97. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.79 while its Price-to-Book (P/B) ratio in mrq is 196.09. Its current Enterprise Value per Revenue stands at 1.379 whereas that against EBITDA is 11.855.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.04, which has changed by 0.8862145 over the last 52 weeks, in comparison to a change of 0.17318606 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $10.32, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is -5.37%, while the 200-Day Moving Average is calculated to be 28.34%.
Shares Statistics:
Over the past 3-months, AVAH traded about 1.38M shares per day on average, while over the past 10 days, AVAH traded about 1237330 shares per day. A total of 208.91M shares are outstanding, with a floating share count of 68.97M. Insiders hold about 66.99% of the company’s shares, while institutions hold 25.68% stake in the company. Shares short for AVAH as of 1765756800 were 3619836 with a Short Ratio of 2.63, compared to 1763078400 on 4452357. Therefore, it implies a Short% of Shares Outstanding of 3619836 and a Short% of Float of 5.2800003.
Earnings Estimates
A comprehensive evaluation of Aveanna Healthcare Holdings Inc (AVAH) is underway, with the input of 11.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.13, with high estimates of $0.15 and low estimates of $0.1.
Analysts are recommending an EPS of between $0.59 and $0.46 for the fiscal current year, implying an average EPS of $0.55. EPS for the following year is $0.59, with 11.0 analysts recommending between $0.72 and $0.37.
Revenue Estimates
10 analysts predict $621.53M in revenue for. The current quarter. It ranges from a high estimate of $644.35M to a low estimate of $609M. As of. The current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $519.87MFor the next quarter, 10 analysts are estimating revenue of $619.51M. There is a high estimate of $635.8M for the next quarter, whereas the lowest estimate is $589.9M.
A total of 10 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.42B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.39B. In the same quarter a year ago, actual revenue was $2.02BBased on 10 analysts’ estimates, the company’s revenue will be $2.57B in the next fiscal year. The high estimate is $2.59B and the low estimate is $2.52B.
